Get the free version of Marbridge Daily delivered to your inbox

Click here to subscribe

Jianke Pharmaceutical Acquires Wuhan Xiong Chu Hospital

iYiou, 6/14/17

Guangdong-based Jianke Pharmaceutical, operator of B2C pharmaceutical e-commerce site, has announced the acquisition of Wuhan-based Xiong Chu Hospital.

The future of internet healthcare relies on a physical presence for long-term growth, said Jianke CEO Xie Fangmin, who further revealed plans to build 6 hospitals across China and partner with hospitals in Beijing, Guangdong, Hubei, Chongqing, and Hainan. The physical hospitals will serve as the basis for Jianke's Internet Hospital, and help accelerate the launch of a chronic disease management project.

Wuhan Xiong Chu Hospital combines healthcare, education, research, prevention, and health maintenance in a single hospital that integrates Western and Traditional Chinese Medicine. "Compared with other cities, first-tier cities such as Guangzhou and Wuhan have superior medical resources," said Xie. Jianke has operations centers in both cities, which will facilitate integration of those medical resources.

Editor's Note: This news follows an announcement from Jianke yesterday that it had obtained a class A online pharmaceuticals transaction services license, allowing the company to operate a third-party online B2B drug trading platform. Jianke now possesses class A, B, and C online pharmaceuticals transaction licenses. For more information on this topic, please see Jianke Secures Online Third-party B2B Drug Trading License, MD 6/13/17 issue.

Keywords: Xie Fangmin e-commerce Internet B2C Jianke online healthcare M&A


Please note, all fields are required.
None of your personal information will be shared with third parties.



The information contained in this newsletter is based upon sources that Marbridge Consulting believes to be reliable, and we have made every effort to translate the original articles or article excerpts as faithfully as possible. However, Marbridge Consulting makes no warranty of and assumes no legal responsibility for the accuracy of either the original source material or the English language translations.

Marbridge Daily Premium

Interested in gaining full access to all newsletter articles and the Marbridge Daily archive? To learn more about premium subscription options, including pricing, please:

Click here

Marbridge Consulting RSS Feed

Marbridge Reports